Goes

Netherlands

40 total trials 16 recruiting

Filter these 40 trials by phase, condition, sponsor and more.

Open in Search →

This study is to find out about the Safety and Efficacy of Epcoritamab in Combination with Rituximab and Lenalidomide (R2) compared to R2 in … Ended recruitment

2023-505628-67-00 5 2022-10-28 Relapsed and Refractory Follicular Lymphoma
SEQUEL-Breast: a phase 2 study on the combination of alpelisib and fulvestrant after progression on previous therapy with fulvestrant in pat … Ended recruitment

2024-514965-20-00 4 2022-06-02 Breast cancer
A Phase 3 Trial of Epcoritamab vs Investigator’s Choice Chemotherapy in R/R DLBCL Ended recruitment

2023-504830-23-00 5 2020-12-16 B-cell Lymphoma
Study Comparing Zanubrutinib (BGB-3111) plus Rituximab Versus Bendamustine plus Rituximab in Patients with Previously Untreated Mantle Cell … Ended recruitment

2023-509908-15-00 10 2020-01-20 Mantle Cell Lymphoma
Liposomal iRInotecan, Carboplatin or oXaliplatin in the first line treatment of esophagogastric cancer: a randomized phase 2 study (LyRICX) Ended recruitment

2023-509287-26-00 4 2019-07-01 previously untreated metastatic or locally advanced esophagogastric ca
HOVON 152 DLBCL. A phase II study evaluating the effect of DA-EPOCH-R induction followed by nivolumab consolidation in patients with newly d … Ended recruitment

2022-501038-48-00 4 2018-07-26 Diffuse Large B-Cell Lymphoma
Endocrine therapy plus CDK 4/6 inhibition in first- or second-line for hormone receptor positive advanced breast cancer - the SONIA study Ended recruitment

2024-516204-42-00 5 2017-11-21 Breast cancer
A Phase III double-blind placebo-controlled Randomised Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients Ended recruitment

2022-502324-48-00 5 2014-08-05 Patients with resected colon carcinoma
Biomarker discovery randomized phase IIb trial with carboplatin-cyclophosphamide versus paclitaxel with or without atezolizumaB as first-lin … Ended recruitment

2024-516202-39-00 4 2013-10-10 Metastatic breast cancer
WOMEN&More: Efficacy, safety, and acceptability of mifepristone 50 mg once-weekly as a contraceptive Ended

2022-502694-41-00 5 2025-04-14 Contraception
A Phase 2 Dose-Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejec … Ended

2023-508736-62-00 4 2024-08-08 Heart failure (HF) with reduced ejection fraction (HFrEF)
A large global trial to evaluate the efficacy and safety of milvexian in reducing recurrent cardiovascular events in patients after a heart … Ended

2022-501418-69-00 5 2023-11-21 Acute Coronary Syndrome
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis … Ended

2023-503794-38-00 5 2022-11-24 Prevention of stroke or systemic embolism in atrial fibrillation
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke Ended

2023-503673-38-00 5 2019-05-24 Adults at high risk of cardiovascular events without prior MI or strok
autologous Transplantation after a Rituximab/Ibrutinib/Ara-c containing iNduction in Generalized mantle cell Lymphoma – a randomized Europea … Ended

2024-511235-10-00 5 2016-07-25 Generalized mantle cell Lymphoma
HD21 Ended

2024-518022-33-00 5 2016-07-15 Advanced Stage of Hodgkin Lymphoma

Showing 25–40 of 40 trials